Project Number 1R41AG053115-01A1 Agency/Funding Organization NIA Funding Year 2016 View Full Project Details for TARGET IDENTIFICATION FOR NOVEL SMALL MOLECULE THERAPEUTIC FOR ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator LOVELL, MARK ANTHONY Principal Investigator First Name MARK Principal Investigator Last Name LOVELL Awardee Organization COPLEX THERAPEUTICS, LLC Awardee State Kentucky Contact PI Country United States Project Detail Funding Opportunity Announcement PA-15-270: PHS 2015-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42]) FY Overall Cost $106,301 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
